Selective serotonin reuptake inhibitors and adverse pregnancy outcomes

This publication has 21 references indexed in Scilit:

• Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
  CMAJ : Canadian Medical Association Journal, 2005
• Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
  BMJ, 2005
• Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
  The Lancet, 2005
• The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feeding
  Journal of Clinical Psychopharmacology, 2005
• Angiotensin II receptor antagonist treatment during pregnancy
  Birth Defects Research Part A: Clinical and Molecular Teratology, 2005
• Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
  Pediatrics, 2004
• Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
  Acta Paediatrica, 2001
• The Vasoactive Effects of Serotonin in Normal and Single Umbilical Artery Cords in Normotensive and Hypertensive Pregnancies
  Hypertension in Pregnancy, 1996
• In Vitro Perfusion Studies on Human Umbilical Arteries: I. Vasoactive Effects of Serotonin, PGF_2α and PGE₂
  Acta Obstetricia et Gynecologica Scandinavica, 1986
• Prospective study of postpartum depression: Prevalence, course, and predictive factors.
  Journal of Abnormal Psychology, 1984